Načítá se...
Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study
Women who inherit a BRCA1 or BRCA2 mutation have an increased risk of breast cancer. Preliminary evidence suggests they may also have defects in bone marrow function. To test this hypothesis, we conducted a multicenter, retrospective, matched cohort study, comparing women with localized breast cance...
Uloženo v:
Vydáno v: | Cancer Med |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
John Wiley and Sons Inc.
2019
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745828/ https://ncbi.nlm.nih.gov/pubmed/31407530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2471 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|